Search results for "FDA update"
New sepsis risk calculator that uses AI approved
The FDA approved an artificial intelligence (AI) program that identifies patients at risk for sepsis and a higher-dose naloxone spray, among other actions.
https://acphospitalist.acponline.org/archives/2024/05/15/new-sepsis-risk-calculator-that-uses-ai-approved.htm
15 May 2024
Antibiotic OKed for pneumonia, bloodstream, skin infections
In addition to approving ceftobiprole medocaril sodium for three different types of infection, the FDA authorized the first generic version of fidaxomicin, among other actions.
https://acphospitalist.acponline.org/archives/2024/04/10/antibiotic-oked-for-pneumonia-bloodstream-skin-infections.htm
10 Apr 2024
First medication for severe frostbite approved
The FDA also warned about smartwatches claiming to measure blood sugar without piercing the skin, among other recent actions.
https://acphospitalist.acponline.org/archives/2024/03/06/first-medication-for-severe-frostbite-approved.htm
6 Mar 2024
Genetic test for opioid disorder risk approved
The new test is to be used prior to patients' first exposure to oral opioids for the treatment of acute pain. Other recent FDA actions include a recall of overly potent IV drugs.
https://acphospitalist.acponline.org/archives/2024/02/07/genetic-test-for-opioid-disorder-risk-approved.htm
7 Feb 2024
New sickle cell therapies approved
The FDA also warned about eye infections with over-the-counter drops and skin reactions to antiseizure medications, among other actions.
https://acphospitalist.acponline.org/archives/2024/01/03/new-sickle-cell-therapies-approved.htm
3 Jan 2024
Surgical devices, ventilators, dialysis machines recalled
The FDA also approved first-time generics for spironolactone oral suspension and calcium gluconate, among other actions.
https://acphospitalist.acponline.org/archives/2023/11/15/surgical-devices-ventilators-dialysis-machines-recalled.htm
15 Nov 2023
New COVID-19 boosters, biosimilar for MS OK’ed
The FDA approved updated COVID-19 vaccines and the first-ever biosimilar for multiple sclerosis (MS), among other recent actions.
https://acphospitalist.acponline.org/archives/2023/10/04/new-covid-19-boosters-biosimilar-for-ms-oked.htm
4 Oct 2023
FDA provides info on stimulant shortage
Also, a sterilizer for 3D-printed medical devices, a drug for postpartum depression, and an RSV vaccine for pregnant patients were approved, among other recent FDA actions.
https://acphospitalist.acponline.org/archives/2023/08/30/fda-provides-info-on-stimulant-shortage.htm
30 Aug 2023
Catheters recalled; warning on troponin tests
The FDA announced a recall of certain peripheral catheters due to leaking and warned not to use a cardiac testing panel providing inaccurate troponin measurements, among other recent actions.
https://acphospitalist.acponline.org/archives/2023/08/02/catheters-recalled-warning-on-troponin-tests.htm
2 Aug 2023
New antibiotic approved for hospital-acquired pneumonia
The FDA approved sulbactam and durlobactam for injection to treat hospital-acquired or ventilator-associated pneumonia caused by susceptible strains of Acinetobacter baumannii-calcoaceticus complex, among other recent actions.
https://acphospitalist.acponline.org/archives/2023/07/05/new-antibiotic-approved-for-hospital-acquired-pneumonia.htm
5 Jul 2023